DFTX
DFTX
NASDAQ · Pharmaceuticals

Definium Therapeutics Inc

$35.12
+1.85 (+5.56%)
Analyst Consensus
Strong Buy
24
Analysts
High
Coverage
Buy 23 96%
Hold 1 4%
Sell 0 0%
Price Target
Analyst Price Target +31.0% upside
Low Target $39.37
Average Target $46.00
High Target $57.04
Current Price $35.12
Current
$35.12
Target
$46.00
$39.37 $46.00 avg $57.04
Scenario Analysis
Bear Case
$39.37
12.1%
Low target
Base Case
$46.00
+31.0%
Avg target
Bull Case
$57.04
+62.4%
High target
Risk/Reward
5.2x
Highly favorable
Price in Context
52-Week High
$49.70
-29.3% from high
52-Week Low
$10.47
+235.6% from low
Target vs 52W High
$46.00
-7.4% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 37 86% $1,330.33 -5.8%
RDY
Dr. Reddy's Laboratories
Sell 42 45% — +0.0%
JNJ
Johnson & Johnson
Buy 30 70% $299.55 +6.2%
MRK
Merck & Co. Inc.
Buy 35 71% $159.27 +7.1%
PFE
Pfizer Inc.
Hold 34 38% $33.90 +16.0%
BMY
Bristol-Myers Squibb Co
Hold 34 41% $174.50 +180.8%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 14 93% $36.26 -47.3%
ZTS
Zoetis Inc
Hold 22 41% $209.87 +154.9%